scispace - formally typeset
S

Sofia Xanthoulea

Researcher at Maastricht University

Publications -  28
Citations -  1659

Sofia Xanthoulea is an academic researcher from Maastricht University. The author has contributed to research in topics: Endometrial cancer & Cytokine. The author has an hindex of 16, co-authored 25 publications receiving 1368 citations. Previous affiliations of Sofia Xanthoulea include Maastricht University Medical Centre.

Papers
More filters
Journal ArticleDOI

Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.

TL;DR: Endothelium-restricted inhibition of NF-kappaB activation resulted in strongly reduced atherosclerotic plaque formation in ApoE(-/-) mice fed with a cholesterol-rich diet and inhibited proinflammatory gene expression at the arterial wall and promotes the pathogenesis of atherosclerosis.
Journal ArticleDOI

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

TL;DR: This review describes the recent technological developments in NGS applied to the field of oncology and a number of clinical applications are reviewed, i.e., mutation detection in inherited cancer syndromes based on DNA- sequencing, detection of spliceogenic variants based on RNA-sequencing, DNA-sequenced to identify risk modifiers and application for pre-implantation genetic diagnosis, cancer somatic mutation analysis, pharmacogenetics and liquid biopsy.
Journal ArticleDOI

Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases

TL;DR: It is shown that knock-in mice expressing a mutated nonsheddable p55TNFR develop Toll-like receptor–dependent innate immune hyperreactivity, which renders their immune system more efficient at controlling intracellular bacterial infections.
Journal ArticleDOI

Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity.

TL;DR: Results indicate that tmTNF preserves a subset of the beneficial activities of TNF while lacking detrimental effects, and support the hypothesis that selective targeting of soluble TNF may offer several advantages over complete blockade of T NF in the treatment of chronic inflammation and autoimmunity.
Journal ArticleDOI

Wound administration of m2-polarized macrophages does not improve murine cutaneous healing responses

TL;DR: The data indicate that despite M2 macrophages exhibit an anti-inflammatory phenotype in-vitro, they do not improve wound closure in wild type mice while they delay healing in diabetic mice, and topical application of ex-vivo generated M2macrophages is not beneficial and contraindicated for cell therapy of skin wounds.